glp-1 obesity drug news october 21 2025 Popular medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds GLP-1 Pill Helped People With

Important context: the FDA has warned that retatrutide is not a component of an FDA-approved drug and has not been found safe/effective for any condition

Clinical studies show no evidence of metabolic acceleration that would offset the natural decline in energy requirements accompanying weight reduction

Then theres trust

When appetite is low, these portions feel manageablenot overwhelming

ELAD reported roughly 50% less grey-matter volume loss with liraglutide than with placebo [10]

Retatrutide has shown favorable effects on various cardiovascular parameters, making it a valuable tool in managing cardiovascular comorbidities